AIG
XFOR icon

American International Group’s X4 Pharmaceuticals XFOR Stock Holding History

American International Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,058
Closed -$85.8K – 2770
2024
Q1 		$85.8K Buy
2,058
+18
+0.9% +$501 ﹤0.01% 2598
2023
Q4 		$51.3K Sell
2,040
-8
-0.4% -$195 ﹤0.01% 2808
2023
Q3 		$67K Buy
2,048
+73
+4% +$3.18K ﹤0.01% 2728
2023
Q2 		$115K Buy
+1,975
New +$101K ﹤0.01% 2489
2021
Q2 		– Sell
-312
Closed -$81 – 3289
2021
Q1 		$81 Hold
312
– – ﹤0.01% 2811
2020
Q4 		$60 Sell
312
-8
-3% -$1.57K ﹤0.01% 2905
2020
Q3 		$65K Sell
320
-8
-2% -$1.92K ﹤0.01% 2762
2020
Q2 		$92K Buy
328
+24
+8% +$6.57K ﹤0.01% 2585
2020
Q1 		$91K Buy
304
+56
+23% +$15.9K ﹤0.01% 2366
2019
Q4 		$80K Sell
248
-2
-0.8% -$717 ﹤0.01% 2734
2019
Q3 		$95K Buy
250
+102
+69% +$40.4K ﹤0.01% 2640
2019
Q2 		$67K Buy
148
+130
+722% +$66.1K ﹤0.01% 2869
2019
Q1 		$10K Sell
18
-1
-5% -$552 ﹤0.01% 3032
2018
Q4 		$8K Hold
19
– – ﹤0.01% 3069
2018
Q3 		$6K Buy
19
+2
+12% +$848 ﹤0.01% 3163
2018
Q2 		$11K Hold
17
– – ﹤0.01% 3066
2018
Q1 		$68K Buy
+17
New +$49.5K ﹤0.01% 2822

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's XFOR Position: Q2 2024 in Review

American International Group sold out of X4 Pharmaceuticals (XFOR) in Q2 2024, closing a stake of 2,058 shares — an estimated $85.8K sold.

American International Group first reported a position in XFOR in Q1 2018 and held it in 17 quarters. The position peaked at $115K in Q2 2023. 98 funds tracked by Wall St. Rank hold XFOR as of Q2 2024.

  • American International Group reported no remaining X4 Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 2,058 X4 Pharmaceuticals shares in Q2 2024, an estimated $85.8K.
  • American International Group first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 17 quarters.
  • American International Group's X4 Pharmaceuticals position peaked at $115K in Q2 2023.
  • 98 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.